These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2724 related articles for article (PubMed ID: 18926712)
1. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus. Chen G; Wang Z; Liu XY; Zhang MY; Liu FY Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Chen G; Wang Z; Liu XY; Liu FY Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580 [TBL] [Abstract][Full Text] [Related]
3. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer]. Zhang MY; Wang Z; Liu XY; Chen G; Liu FY Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527 [TBL] [Abstract][Full Text] [Related]
4. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases]. Chen G; Wang Z; Liu XY; Liu FY Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760 [TBL] [Abstract][Full Text] [Related]
5. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus]. Wu J; Chai Y; Zhou XM; Chen QX; Yan FL Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797 [TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776 [TBL] [Abstract][Full Text] [Related]
7. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma]. Wang Z; Liu XY; Liu FY Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer. Chen H; Wang Z; Yang Z; Shang B; Liu X; Chen G Ann Surg Oncol; 2013 Aug; 20(8):2721-6. PubMed ID: 23463093 [TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
10. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. Chen G; Wang Z; Liu XY; Liu FY World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905 [TBL] [Abstract][Full Text] [Related]
11. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy]. Zhang DK; Su XD; Lin P Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605 [TBL] [Abstract][Full Text] [Related]
12. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma]. Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501 [TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment and prognosis in patients with squamous cell carcinoma of thoracic esophagus]. Zhang DK; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Ma GW; Zhu ZH; Dai Y; Rong TH Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(17):1333-6. PubMed ID: 19094566 [TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185 [TBL] [Abstract][Full Text] [Related]
16. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma. Song L; Liu Y; Wang Z; Ren WG; Liu XY Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231 [TBL] [Abstract][Full Text] [Related]
17. [Recurrence pattern and prognosis of esophageal cancer following tumor resection]. Chen J; Sang M; Chen Y Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):293-5. PubMed ID: 10920988 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024 [TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma]. Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]